MedTrace Logo

Effectiveness of Safe Drinking Water in Treatment of Severe Acute Malnutrition (Pakistan)

NCT02751476 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 820

Last updated 2017-01-31

No results posted yet for this study

Summary

This study builds evidence on the importance of using safe drinking water during the nutritional treatment of children affected by Severe Acute Malnutrition (SAM). The following hypotheses will be tested: 1.The addition of safe drinking water to SAM treatment will reduce exposure to pathogens that cause diarrhoeal disease, thereby reducing diarrhoea incidence among enrolled children. 2.Reductions in pathogen exposure and diarrhoeal disease will result in shorter recovery pe-riods for children with SAM. The study will evaluate the effectiveness of safe drinking water in reducing SAM treatment cost and duration and will provide recommendations for improving SAM treatment protocols.

Conditions

  • Marasmus

Interventions

OTHER

Point of Use (PoU) water treatment flocculent disinfectant.

A household level point of use water treatment of a flocculent disinfectant will be tested.

OTHER

Point of Use (PoU) water treatment chlorine disinfectant

A household level point of use water treatment of a chlorine disinfectant will be tested.

DEVICE

Point of Use (PoU) ceramic water filter

A household level point of use water treatment of a ceramic water filter will be tested.

OTHER

Standard Severe Acute Malnutrition Treatment

Standard CMAM treatment.

Sponsors & Collaborators

Principal Investigators

  • Shannon Doocy, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-10-31
Completion
2017-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02751476 on ClinicalTrials.gov